编程死亡-1 抑制剂 免疫疗法诱导的症状性毒性甲状腺结节
Owen Cole1, Prahasith Kamani1, Vikash Kumar1
1Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.
Cureus
|March 18, 2024
概括
编程死亡配体1 (PD-L1) 抑制剂可以导致甲状腺问题. 这份病例报告详细介绍了一名患者在PD-L1抑制剂治疗期间发展出有毒的甲状腺结节,这表明需要进一步研究的联系.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 免疫检查点抑制剂,特别是PD-L1抑制剂,是癌症治疗的重要手段.
- 甲状腺功能障碍是这些治疗的已知的副作用,通常是甲状腺功能低下症.
- 甲状腺功能障碍是不太常见但有记录的不良影响.
研究的目的:
- 在接受PD-L1抑制剂的患者中报告有毒甲状腺结节形成的病例.
- 调查使用PD-L1抑制剂与甲状腺结节的发展或恶化之间的潜在关联.
- 强调需要进一步研究PD-L1抑制剂诱导的甲状腺功能障碍的机制.
主要方法:
- 案例报告的呈现方式.
- 审查患者的病史和治疗过程.
- 甲状腺功能和结节特征的分析.
主要成果:
- 一名接受PD-L1抑制剂阿维卢马布治疗梅克尔细胞癌的患者出现了有毒的甲状腺结节.
- 这种不良事件表明PD-L1抑制剂治疗与甲状腺结节形成之间可能存在联系.
结论:
- PD-L1 抑制剂可能与甲状腺结节的发展或恶化有关.
- 需要进一步的研究,以阐明PD-L1抑制剂诱导的甲状腺功能过高和甲状腺结节形成的具体机制.
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907